Shopping Cart
- Remove All
Your shopping cart is currently empty
ERK-IN-4 is a cell-permeable ERK inhibitor with potential antiproliferative effects for the study of diseases caused by immune dysfunction.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $40 | In Stock | |
| 2 mg | $55 | In Stock | |
| 5 mg | $89 | In Stock | |
| 10 mg | $147 | In Stock | |
| 25 mg | $243 | In Stock | |
| 50 mg | $359 | In Stock | |
| 100 mg | $537 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $106 | In Stock |
| Description | ERK-IN-4 is a cell-permeable ERK inhibitor with potential antiproliferative effects for the study of diseases caused by immune dysfunction. |
| Targets&IC50 | ERK2:5 μM (Kd) |
| In vitro | In HeLa, A549, or SUM-159 cells, ERK-IN-4 (10 µM-150 µM, 10 days) completely inhibits cell proliferation[1]. |
| Synonyms | ERK Inhibitor |
| Molecular Weight | 328.814 |
| Formula | C14H17ClN2O3S |
| Cas No. | 1049738-54-6 |
| Smiles | Cl.O=C1SC(=CC2=CC=C(OCC)C=C2)C(=O)N1CCN |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 15 mg/mL (45.62 mM), Sonification is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.08 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.